Evidence map›Paper›PMID 37935008›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Autoimmunity and Freiburg classification in common variable immunodeficiency].

Diana Andrea Herrera-Sánchez, Nancy Valeria López-Moreno, Laura Berrón-Ruiz, Gustavo Jonny Ramos-Blas, Rocío Catana-Hernández, Patricia María O'Farrill-Romanillos

Open access · greenAbstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diana Andrea Herrera-SánchezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica. Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.ORCID 0000-0003-1621-6976
Nancy Valeria López-MorenoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica. Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.ORCID 0000-0002-6309-5663
Laura Berrón-RuizSecretaría de Salud, Instituto Nacional de Pediatría, Laboratorio de Inmunodeficiencias Primarias. Ciudad de México, México.ORCID 0000-0002-3290-8705
Gustavo Jonny Ramos-BlasInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Hematología, Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.ORCID 0000-0001-5785-6924
Rocío Catana-HernándezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Reumatología, Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.ORCID 0000-0001-8510-3030
Patricia María O'Farrill-RomanillosInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Servicio de Alergia e Inmunología Clínica. Clínica de Errores Innatos de la Inmunidad. Ciudad de México, México.ORCID 0000-0002-7186-1372
Mexican Social Security Institute · MXSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Up to 25% of patients with common variable immunodeficiency (CVID) debut with autoimmunity, which is related to the Freiburg classification, which is based on flow cytometry. Objective: to determine the frequency and type of autoimmune diseases and their association with the Freiburg classification in adults with CVID. Methods: A cross-sectional, analytical and observational study was carried out with 33 patients belonging to the Primary Immunodeficiency Clinic of a third level hospital, with a diagnosis of CVID. They were divided into 3 phenotypes according to the Freiburg classification. Results: Of the 33 patients studied, 66.6% presented autoimmune diseases, 19 of them (86.3%) had cytopenia; 42.1% belonged to Freiburg group Ia, 36.8% to Ib and 21% to phenotype II. In 36.6% of the patients, autoimmune cytopenia were the first manifestation of CVID; and up to 70% of them belong to the Freiburg phenotype Ia (p = 0.086). Patients with autoimmune cytopenia had a lower percentage of isotype-switched memory B cells (p = 0.018), no higher percentage of CD21low B cells (p = 0.226). Conclusions: Classification by CVID phenotypes allows the identification of the patient's profile according to the percentage of memory B cells with isotype change, which is useful to intentionally search for non-infectious complications of the disease.

Indexed as

Autoimmune DiseasesCommon Variable ImmunodeficiencyAdultAutoimmunityB-LymphocytesCross-Sectional StudiesHumansAutoimmune DiseasesAutoimmunityAutoinmunidadCommon Variable ImmunodeficiencyEnfermedades AutoinmunesFreiburgInmunodeficiencias PrimariasInmunodeficiencia Variable ComúnPrimary Immunodeficiencies

Identifiers

PMID37935008
PMCPMC10752652
OpenAlexW4388500376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.